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Background: Electrical stimulation applied to individual organs, peripheral nerves, or specific brain re-
gions has been used to treat a range of medical conditions. In cardiovascular disease, autonomic
dysfunction contributes to the disease progression and electrical stimulation of the vagus nerve has been
pursued as a treatment for the purpose of restoring the autonomic balance. However, this approach lacks
selectivity in activating function- and organ-specific vagal fibers and, despite promising results of many
preclinical studies, has so far failed to translate into a clinical treatment of cardiovascular disease.
Objective: Here we report a successful application of optogenetics for selective stimulation of vagal
efferent activity in a large animal model (sheep).
Methods and results: Twelve weeks after viral transduction of a subset of vagal motoneurons, strong
axonal membrane expression of the excitatory light-sensitive ion channel ChIEF was achieved in the
efferent projections innervating thoracic organs and reaching beyond the level of the diaphragm. Blue
laser or LED light (>10 mW mm2; 1 ms pulses) applied to the cervical vagus triggered precisely timed,
strong bursts of efferent activity with evoked action potentials propagating at speeds of ~6 m s1.
Conclusions: These findings demonstrate that in species with a large, multi-fascicled vagus nerve, it is
possible to stimulate a specific sub-population of efferent fibers using light at a site remote from the
vector delivery, marking an important step towards eventual clinical use of optogenetic technology for
autonomic neuromodulation.
© 2020 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).the vagus nerve; LED, light
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Electroceuticals are devices that treat medical conditions by
application of electrical stimulation to individual peripheral nerves,
specific brain regions, organs, or transcutaneously. Therapeutic
electroceutical treatments have been trialed in a range of condi-
tions characterized by autonomic dysfunction, including heart
failure, hypertension, autoimmune and inflammatory diseases [1].
One such treatment, vagus nerve stimulation (VNS), was developedle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
L.C. Booth, S.T. Yao, A. Korsak et al. Brain Stimulation 14 (2021) 88e96with the aim of redressing the autonomic imbalance in cardiovas-
cular disease by increasing the activity of the parasympathetic arm
of the autonomic nervous system, via application of electrical cur-
rent pulses to the vagus nerve at the cervical level [2e5]. However,
the promising results obtained with this approach in preclinical
studies failed to translate to the clinic, likely due to the complexity
of the vagus nerve and the non-selective nature of electrical VNS.
For example, large trials of electrical VNS in hundreds of heart
failure patients failed to demonstrate benefits with respect to the
primary endpoints despite strong pre-clinical data [6].
The vagus nerve is a mixed nerve that innervates the majority of
the viscera and contains afferent sensory and efferent motor vagal
fibers at an approximate ratio of 4:1 as well as sparse sympathetic
fibers [7e9]. Electrical stimulation of mixed nerves does not
discriminate between the various subsets of afferent and efferent
fibers, nor between the functional subtypes of each of these groups
of fibers. Stimulation of the cervical vagus (a common site for VNS
due to the relative ease of access) preferentially activates sensory
fibers as they have a lower activation threshold than the efferent
fibers [10]. As such, stimulations with currents that are sufficient to
activate efferent fibers also capture vagal afferents, resulting in
undesirable side effects [11,12]. To increase the efficacy of VNS
while minimizing the side effects, the development of novel
methods allowing selective stimulation of specific functional
groups of vagal fibers is highly desirable.
The required level of selectivity can be achieved by transducing
functional populations of vagal neurons to express native or
modified light-sensitive ion channels derived from algae [13]. This
approach allows stimulation of electrical activity using light and
had become a mainstream tool in neuroscience called optogenetics
[13,14]. Several reports have demonstrated the use of optogenetic
tools to stimulate peripheral nerves in rodents, some involving
wireless technologies [15e23]. However, if optogenetic techniques
are to be translated to the clinic, the feasibility and efficacy of using
light to stimulate neuronal pools or select fibers in peripheral
nerves need to be demonstrated in clinically relevant large animal
models.
Here we report the successful application of optogenetics for
selective stimulation of the efferent axons of vagal preganglionic
neurons, whose somata are located in the dorsal motor nucleus of
the vagus nerve (DVMN) in sheep. We show that 12 weeks after
viral transduction of a subset of vagal motoneurons, strong axonal
membrane expression of the excitatory light-sensitive ion channel
ChIEF is achieved in the projections innervating thoracic organs and
reaching beyond the level of the diaphragm. This allows selective
stimulation of vagal efferent fibers using light (optoVNS) applied to
the nerve at the cervical level or near the target organs.Materials and methods
Genetic targeting of vagal preganglionic neurons
Vagal preganglionic neurons of the DVMN were transduced to
express the light-sensitive channel ChIEF fused to the fluorescent
protein tdTomato (ChIEF-tdTomato) [24]. ChIEF is a chimeric
channelrhodopsin derivative constructed from the N-terminal part
of channelrhodopsin 1 and the C-terminal part of channelrhodop-
sin 2. ChIEF combines the reduced inactivation characteristics of
channelrhodopsin 1 with the more favorable cation permeability
properties of channelrhodopsin 2 [24]. The I170V mutation further
improves the channel closure kinetics. In comparison to channelr-
hodopsin 2, ChIEF produces greater photocurrents, allows better
temporal control of neuronal activity by light pulses, and shows
more efficient membrane expression and trafficking [24].89Vagal preganglionic neurons characteristically express the
transcriptional factor Phox2 allowing selective targeting of these
neurons using viral vectors driving the transgene expression under
the control of the PRSx8 promoter constructed by multimerization
of the Phox2 binding sites [25]. In the dorsal brainstem, only the
DVMN neurons, a subset of neurons in the neighbouring nucleus of
the solitary tract and sparse neurons of the area postrema express
Phox2 transcription factors. Therefore, the PRSx8 promoter can
only be active in these populations of cells. However, it appears that
not all cells which express Phox2 efficiently drive the PRSx8 pro-
moter. In our previous studies in rats we observed the strongest
PRSx8-driven transgene expression in the DVMN with only sparse
labelling in neurons of the adjacent areas [26e29].
Lentiviruses were derived from the four-plasmid (pTYF trans-
ducing, pNHP packaging, VSVg envelope and pTAT plasmids) HIV-
1-based self-inactivating lentiviral vector (LVV) system, pseudo-
typed with the VSV-G envelope [30,31]. A detailed description of
the methods used to generate and characterize these vectors has
been reported previously [31,32]. Transgene expression driven
under the control of the PRSx8 promoter was enhanced by the
chimeric transactivator consisting of a GAL4-binding domain fused
to a part of the transcriptional activation domain of NF-kBp65, and
the multimerized GAL4-binding sequences (G4BS), as described
[33]. The titer of the virus was 7.7  1010 IU ml1, determined by
qPCR performed on transduced cells, as described [34].
Validation of this vector system in targeting the DVMN neurons
has been described in detail previously [26,28]. Single-cell re-
cordings in rat brainstem slices demonstrated that 445e475 nm
light triggered precisely timed depolarizations and action potential
firing in DVMN neurons transduced to express ChIEF [26].
Experiments in rats
Validation experiments were first performed in young adult
male Sprague-Dawley rats (200e250 g; n ¼ 5). The study was
conducted in accordance with the European Commission Directive
2010/63/EU (European Convention for the Protection of Vertebrate
Animals used for Experimental and Other Scientific Purposes) and
the UK Home Office (Scientific Procedures) Act (1986) with project
approval from the University College London Institutional Animal
Care and Use Committee. The rats were group-housed and main-
tained on a 12-h light cycle (lights on 07:00) and had ad libitum
access to water and food.
Rats were anaesthetized with ketamine (60 mg kg1; i.m.) and
medetomidine (250 mg kg1; i.m.). Adequate depth of surgical
anesthesia was maintained and confirmed by the absence of a
withdrawal response to a paw pinch. The animal was placed in a
stereotaxic frame and a midline dorsal neck incision was made to
expose the dorsal brainstem surface. One microinjection of LVV-
PRSx8-ChIEF-tdTomato (0.5 ml at a rate of 0.1 ml min1) was made to
the right DVMN using the following coordinates: 0.5 mm rostral,
0.6 mm lateral and 0.8 mm ventral from the calamus scriptorius.
After the microinjections, the wound was sutured and anesthesia
was reversed with atipamezole (1 mg kg1, i.m.). For postoperative
analgesia the animals received buprenorphine (0.05 mg kg1 per
day, s.c.) for 3 days. No complications were observed after the
surgery and the animals gained weight normally.
Four weeks after microinjections of the viral vector, rats were
anaesthetized with urethane (induction: 1.3 g kg1, i.p.; mainte-
nance: 10e25 mg kg1 h1, i.v.) and instrumented as described in
detail previously [35,36]. Adequate depth of anesthesia was
monitored and confirmed by the stability of arterial blood pressure
and heart rate recordings which did not show responses to a paw
pinch. The femoral artery and vein were cannulated for the mea-
surements of blood pressure and the administration of anesthetic,
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latedwith oxygen-supplemented air using a small rodent ventilator
(tidal volume ~1 mL per 100 g of body weight; ~60 strokesmin1).
PO2, PCO2, and pH of the arterial blood were measured regularly
and kept within physiological ranges (PO2 95e105 mmHg; PCO2
35e45mmHg and pH 7.35e7.45) by adjusting the tidal volume and/
or ventilator frequency as well as the level of supplemental oxygen.
Body temperature was maintained at 37.0 ± 0.5 C. The animal was
placed in a stereotaxic frame and the dorsal brainstem was
exposed. For optical stimulation, laser light (445 nm) was delivered
to the dorsal brainstem surface via an optrode with a diameter of
0.2 mm (Art Photonics, Berlin, Germany). The right vagus nervewas
dissected, isolated from the surrounding tissues, placed on silver
wire recording electrodes and covered with dental impression
material. The recorded signal was amplified (  10,000), filtered
(80e1500 Hz), and sampled at a rate of 5 kHz.
Experiments in sheep
The experiments were performed in accord with the National
Health and Medical Research Council of Australia guidelines and
were approved by the Animal Ethics Committee of the Florey
Institute of Neuroscience and Mental Health. Merino ewes (1e2
years old; 35e45 kg body weight) were group-housed on a natural
light cycle and were given free access to water and 800 g oaten
chaff per day. The animals were fasted on the day before the
surgery.
Anesthesia was induced with sodium thiopentone (15 mg kg1,
i.v.) and, after endotracheal intubation, was maintained with
1.5e2.0% isoflurane in oxygen-supplemented air. Sheep were then
secured in a custom-built stereotaxic frame. Adequate depth of
surgical anesthesia was maintained and confirmed by lack of a
corneal reflex. The animals were treated with intramuscular anti-
biotic (penicillin, 900 mg) at surgery and for 2 days post-
operatively. Analgesia was maintained with intramuscular flu-
nixin meglumine (1 mg kg1) at surgery and for 4-h post-surgery.
After incision of the overlying skin, the nuchal muscles were
dissected, and occipital bone was partially removed to expose the
caudal part of the cerebellum. The cerebellum was carefully raised
to expose the fourth ventricle and the area postrema. Neurons of
the left DVMN were targeted to express ChIEF-tdTomato. Three
microinjections (3 ml each) of LVV-PRSx8-ChIEF-tdTomato were
placed 2mm below the surface of the brainstem at the mid-point of
area postrema (1 mm lateral from the midline), at the level of the
obex (2mm lateral) and 2mm caudal from obex (2mm lateral). The
micropipette was left in place for 5 min after each microinjection.
At the end of the surgery, the dura, nuchal muscles and skin were
separately sutured and the sheep were weaned off anesthesia. No
complications were observed after the surgery.
After a minimum period of 9 weeks (average 12 ± 2 weeks,
range 9e17 weeks), to allow for a high and stable level of ChIEF-
tdTomato expression in the DVMN cell bodies and axons, sheep
were anaesthetized as described above. Adequate depth of anes-
thesia was ensured by lack of a corneal reflex. The animal was
intubated and mechanically ventilated with oxygen-supplemented
air (tidal volume 500 mL; ~12 strokesmin1). The body tempera-
ture was maintained at ~38 C and oxygen saturation was moni-
tored. The left cervical vagus nerve was dissected, isolated from the
surrounding tissues and sectioned. The distal end of the vagus
nerve was then separated into four fascicle bundles. A small section
of each of the bundles was removed and examined under the mi-
croscope to assess the expression of tdTomato in vagal fibers. The
fascicle bundle showing the highest level of tdTomato expression
was placed over a pair of silver wire hook electrodes submerged in
a paraffin oil pool made by suturing of the surrounding skin. An90earth electrode was placed against the muscle near the recording
site. The vagal efferent activity was amplified (  2000), filtered
(1e100 Hz), and sampled at a rate of 5 kHz.
For optical stimulation of the DVMN axons at the cervical level,
the proximal region (55e70 mm from the recording electrodes) of
the nerve was illuminated with either blue laser light (473 nm,
12 mW) via an optic fiber (1 mm in diameter) or an LED (Cree XPE2
Blue 475 nm; for light intensity measurement and calibration see
Supplementary Text and Supplementary Table 1). Pulses of light (1,
2, and 5 ms) were delivered at a frequency of 1 Hz for 300 s. In one
animal, the head was secured in a stereotaxic frame and the dorsal
brainstem was exposed to allow stimulation of the DVMN cell
bodies by application of laser light (473 nm) delivered to the dorsal
brainstem surface via an optic fiber (1 mm in diameter). In another
preparation, in addition to stimulation and recording of the cervical
vagus nerve, a recording was made in the thoracic region of the
vagus just proximal to the cardiac branch. The fifth rib was
removed, and the vagus nerve in the thoracic cavity was identified,
isolated, and placed on the recording electrodes. Light stimulation
of the nerve was applied at the cervical level using the LED (1 Hz,
5 ms pulses, 300 s). In one animal, the cervical vagus was stimu-
lated using electrical current pulses (0.2e20 V, 1e2 ms, 1 Hz) with
recordings made 70 mm distal to the stimulating electrodes, as
described [37].
Histology
At the end of the experiments, the animals were given a ter-
minal dose of pentobarbitone sodium (100 mg kg1, i.v.). After
perfusion via the carotid arteries with 0.9% saline followed by ice-
cold 4% (w/v) paraformaldehyde, the brain was removed. The cer-
vical vagus nerve, the vagus nerve proximal to the cardiac branch,
the cardiac branch of the vagus nerve, the vagus nerve distal to the
cardiac branch and the nodose ganglia were removed and fixed in
4% paraformaldehyde in phosphate-buffered saline (0.1 M, pH 7.4)
for 24e48 h. After cryoprotection (20% sucrose), the tissues were
frozen and sectioned (30 mm) to determine the extent of ChIEF-
tdTomato expression by the DVMN neuronal cell bodies and pro-
jecting axons. Sections of the nerve were stained for Protein Gene
Product 9.5 (PGP9.5) using rabbit anti-Human PGP9.5 antibody
(Cedarlane, Ontario, Canada; 1:1000) and Alexa 488 conjugated
secondary anti-rabbit IgG antibody (Jackson ImmunoResearch;
1:500) and coverslipped with mounting medium containing DAPI
(Sigma-Aldrich). Images were taken at 20 using a Zeiss Axio
Imager M2 with ApoTome.
Data acquisition and analysis
Recordings were obtained and analyzed using Spike2 software
(Cambridge Electronic Design, Cambridge, UK). Neurograms were
generated by averaging 300 sweeps and peaks were considered the
maximum value. Data are reported as individual values and
means ± s.e.m.
Results
Optogenetic vagus nerve stimulation in rats
First, in experiments in rats we confirmed that vagal efferent
activity can be reliably stimulated by light activation of DVMN
neurons expressing ChIEF and characterized the properties of
DVMN neurons in this species. DVMN neurons were transduced to
express ChIEF-tdTomato (Fig. 1a). Four weeks after the microin-
jections of the viral vector, the rats were anaesthetized and laser
light (445 nm, 1e100 ms pulses) was applied to the dorsal
Fig. 1. Optogenetic stimulation and properties of vagal preganglionic neurons of the dorsal motor nucleus of the vagus nerve (DVMN) in rats. (a) Photomicrographs of the coronal
sections of the rat brainstem taken at low (top left) and high (bottom left) magnification illustrating representative examples of ChIEF-tdTomato expression in the DVMN (Bregma
level: 13.8 mm). Neurons display specific membrane localization of the transgene expression. The image on the right illustrates DVMN neuronal projections expressing ChIEF-
tdTomato visualized in a whole mount preparation of the right cervical vagus nerve. Solid arrows point at the projecting axons of the transduced DVMN neurons; open arrows
point at severed neuronal processes within the nucleus; broken while lines outline transduced DVMN neurons. CC, central canal. VN, vagus nerve. XII, hypoglossal motor nucleus.
Scale bars: 200 mm (top left), 20 mm (bottom left), 500 mm (right). (b) Schematic drawing of the experimental setup in an anaesthetized rat instrumented for stimulation of the
DVMN neurons expressing ChIEF-tdTomato by application of blue laser light (via an implanted optrode) and recording of the efferent activity of the vagus nerve at the cervical level.
(c) Stimulus-triggered averages and (d) rectified and smoothed averages (300 sweeps) of the evoked efferent vagus nerve mass action potentials induced by pulses of light of
increasing duration delivered at 1 Hz to stimulate the DVMN vagal preganglionic neurons expressing ChIEF-tdTomato (n ¼ 4).
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nerve was recorded (Fig. 1c and d). Robust bursts of efferent vagal
activity were recorded in response to 1 ms light pulses applied to
the DVMN (Fig. 1c and d). Increasing the duration of the laser light91pulses led to the increases in the magnitude and duration of the
recorded mass action potentials (Fig. 1c and d). The peak of evoked
efferent activity was recorded 27 ± 2 ms and 29 ± 2 ms after the
onset of the 1 and 2 ms light pulses, respectively, indicating that
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~0.8 m s1. Longer light pulses (10, 20, 100 ms) evoked two peaks of
efferent activity occurring 12 ± 1 ms and 31 ± 1 ms after the pulse
onset (Fig. 1c and d), suggesting that in rats, the longer light stimuli
also activate DVMN neurons with axons conducting at ~2 m s1.Expression of ChIEF-tdTomato by DVMN neurons in sheep
Experiments in sheep (n¼ 6) were conducted 12 ± 2weeks after
the injections of the same viral vector into the left DVMN. Strong
expression of ChIEF-tdTomato was observed in the DVMN neurons
along themid to rostral axis of the nucleus (Fig. 2a), as well as in the
axons of these neurons projecting ventrolaterally through the
brainstem (Fig. 2aii). The expression of ChIEF-tdTomato was mostly
confined to the population of the DVMN vagal preganglionic neu-
rons as no tdTomato fluorescence was observed in the neighbour-
ing nucleus of the solitary tract or the hypoglossal nucleus (Fig. 2a).
Limited transduction was detected in the area postrema, possibly
due to some spillover of the vector at the time of the injection. No
expression of tdTomato was observed in the neurons of the nodose
ganglia, indicating that microinjections of the viral vector into the
dorsal brainstem did not result in the transduction of vagal affer-
ents (Supplementary Fig. 1). With viral injections placed into the
left DVMN, no transgene expression was observed in the right
vagus nerve (Supplementary Fig. 2).
Application of laser light (473 nm) to the dorsal brainstem of an
anaesthetized sheep expressing ChIEF-tdTomato in the DVMN
neurons triggered mass action potentials, as recorded from the
cervical vagus, indicating efferent axonal activation (Fig. 2b and c).
Bursts of efferent vagus nerve action potential firing were recorded
in response to 5 or 100 ms light pulses applied to the DVMN
(Fig. 2c). Light pulses of 2 ms in duration were insufficient to reli-
ably evoke efferent activity.Fig. 2. Viral transduction and optogenetic stimulation of the DVMN vagal preganglionic neur
low (top) and high (bottom) magnification illustrating representative examples of ChIEF-tdT
DVMN neurons. 4V, fourth ventricle. AP, area postrema. NTS, nucleus of the solitary tract. Sca
in an anaesthetized sheep instrumented for stimulation of the DVMN neurons expressing Ch
the vagus nerve at the cervical level. (c) Stimulus-triggered averages (300 sweeps) of the evo
duration delivered at 1 Hz to stimulate the DVMN neurons expressing ChIEF-tdTomato in s
92The extent of ChIEF-tdTomato expression in vagal fibers was
next examined at different levels of the nerve including the left
cervical region, the cardiac branch of the left vagus nerve as well as
the thoracic vagus proximal and distal to the cardiac branch (n ¼ 6;
representative examples are shown in Fig. 3 and Supplementary
Figs. 3e5). Strong expression of tdTomato was observed in
efferent fibers at all levels of the vagus nerve examined (Fig. 3;
Supplementary Figs. 3e5). The numbers of efferent axons
expressing ChIEF-tdTomato varied significantly between different
fascicles of the nerve, with some fascicles showing abundant
tdTomato fluorescence and some fascicles displaying low, or no,
tdTomato fluorescence (Fig. 3).Optogenetic vagus nerve stimulation in sheep
To benchmark light-activation of vagal efferents in sheep, we
first characterized electrical properties of vagal fibers at the cervical
level in this species. As expected, it was found that vagal fibers
propagate action potentials with velocities between ~1 and
25 m s1 (Fig. 4b,f). Vagal A-fibres had a threshold of activation of
0.3 V and mean conduction velocity of 23.8 m s1, B-fibres had a
threshold of activation of 4 V and mean conduction velocity of
8.5 m s1, and for C-fibres these values were 6 V and 1.2 m s1,
respectively (Fig. 4b,f).
Blue laser (473 nm) or LED (475 nm) light, applied to the cervical
vagus nerve of anaesthetized sheep (n ¼ 6) which were transduced
to express ChIEF by the DVMN neurons, triggered robust bursts of
efferent activity, as recorded 55e70 mm distal to the site of light
application (Fig. 4cee). The mean calculated conduction velocity of
vagal efferent fibers was 6.1 ± 0.5 m s1 (n ¼ 6; Fig. 4f). Varying the
light pulse duration between 1 and 10 ms had little effect on the
magnitude of the evoked efferent vagus nerve mass action poten-
tials (Fig. 4c and d). Pulses of light delivered by the LED applied toons in sheep. (a) Photomicrographs of coronal sections of the sheep brainstem taken at
omato expression in the DVMN. Arrows point at the projecting axons of the transduced
le bars: 400 mm (top), 100 mm (ai, aii). (b) Schematic drawing of the experimental setup
IEF-tdTomato by application of blue laser light and recording of the efferent activity of
ked efferent vagus nerve mass action potentials induced by pulses of light of increasing
heep.
Fig. 3. Expression of ChIEF-tdTomato by vagal efferent fibers originating from the DVMN, visualized at the cervical level in sheep. (a) Representative cross-section of the whole
cervical vagus nerve showing expression of ChIEF-tdTomato (red), Protein Gene Product 9.5 (PGP9.5) immunoreactivity (green) and 40 ,6-diamidino-2-phenylindole (DAPI) staining
(blue). Scale bar: 500 mm. (b) Photomicrograph of six fascicles taken at a higher magnification showing the expression of ChIEF-tdTomato (red), PGP9.5 immunoreactivity (green)
and DAPI staining (blue) merged; bi, bii and biii show individual stains. Scale bars: 100 mm. (For interpretation of the references to colour in this figure legend, the reader is referred
to the Web version of this article.)
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the vagal branch within the thoracic cavity (Supplementary Fig. 6).
Light stimulation was next delivered to the whole vagus nerve
with the LED positioned at distances of 0 (LED touching the nerve),
1, 3, 5 and 7 mm from the nerve, such that the intensity of light
applied to the nerve was systemically varied in order to determine
the light power intensity threshold required for stimulation of the
transduced fibers (Fig. 4e). The light intensity measurement and
calculation are provided in the Supplementary Text and
Supplementary Table 1. Robust bursts of efferent activity were
induced by pulses of LED light applied with 11 mWmm2 intensity
(Fig. 4e). Stimulations with light intensities of 5 mW mm2 or less
were insufficient to trigger action potential firing in vagal axons
expressing ChIEF (Fig. 4e).Discussion
This study demonstrates the feasibility of viral vector targeting
of vagal motoneurons to express light-sensitive ion channels and93local delivery of light for specific stimulation of vagal efferent ac-
tivity in large animals. The data show that light stimulation can be
applied to the projecting axons of the transduced neurons at a
significant distance from the site of the viral vector delivery. To the
best of our knowledge, this is the first successful application of an
optogenetic technique to selectively stimulate specific neuronal
projections within a large mixed nerve, where the transduced
axons constitute only a small proportion of all fibers. We show that
optoVNS can be applied to stimulate vagal efferents at the cervical
level, - the usual site at which the VNS is applied in humans. The
ability to stimulate a select group of efferent fibers circumvents the
limitations imposed when using electrical VNS where high stimu-
lation intensities are required to activate efferent nerve fibers,
invariably also recruiting afferent fibers, and where discrimination
between the groups of fibers in a mixed nerve is impossible to
achieve. Therefore, this study represents an important step forward
in the development of optogenetic technology for targeted auto-
nomic neuromodulation in future experimental pre-clinical studies
and eventually in clinical use. Our recent study demonstrated that
Fig. 4. Optogenetic stimulation and properties of vagal efferent fibers originating from the DVMN in sheep. (a) Schematic drawing of the experimental setup in an anaesthetized
sheep instrumented for electrical or optical stimulation of the nerve and recording of vagal activity at the cervical level. (b) Averages of the evoked vagus nerve mass action
potentials induced by whole-nerve electrical stimulation illustrating stimulus intensity-dependent recruitment of A, B and C fibres in sheep. (c) Representative examples of the
recordings obtained in two individual animals and (d) group data (n ¼ 4), illustrating stimulus-triggered averages of the evoked efferent vagus nerve mass action potentials, induced
by pulses of laser light of increasing duration delivered to the nerve at the cervical level, proximal to the recording site. (e) Stimulus-triggered averages of the evoked efferent vagus
nerve mass action potentials (MAP) induced by pulses of LED light delivered from a variable distance to the nerve in order to determine the light power threshold, required for
activation of the transduced fibers. Light powers indicated are in mW per mm2. (f) Indicative values (black symbols) denoting the mean conduction velocities that define A, B and C
vagal fibres and the group data illustrating the calculated velocities of action potential propagation, recorded in vagal efferent fibers originating from the DVMN in sheep (red
symbols, n ¼ 6).
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DVMN neurons effectively preserves left ventricular function in
experimental model of heart failure in rats [38].
We show that sheep vagal motoneurons can be effectively
transduced to express a gene of interest (in this study the opto-
genetic actuator ChIEF) under the control of the PRSx8 promoter.
Similar to the profile of PRSx8-driven expression of transgenes in
the brainstem achieved in rodents [26e29], we found that the
DVMN neurons in sheep are highly sensitive to the PRSx8-bearing
vectors. In sheep, ChIEF-tdTomato expression was strongest in the
DVMN with only sparse labelling observed in the adjacent areas of
the dorsal brainstem.
Crucial to our ability to stimulate targeted neurons peripherally,
the light-sensitive ChIEF channel fused with the fluorescent protein
tdTomato was eventually inserted into the membranes along the
whole length of the DVMN neuronal axons. We did not perform
dedicated experiments to determine the minimum time period
required for ChIEF-tdTomato expression to reach the cervical level.
Twelve weeks after the microinjections of the viral vector into the
DVMN, strong tdTomato fluorescence was observed in the vagal
fibers at the cervical level, in the cardiac branch of the vagus nerve
and in the thoracic vagus distal to the heart, reaching the level of
the diaphragm (~0.3e0.5 m from the brainstem). One of the ani-
mals was used in the experiment nine weeks after the vector mi-
croinjections, therefore, nine weeks time period appears to be
sufficient to establish robust expression of light-sensitive channels
in vagal efferent projections at the cervical level. This indicates that
the axonal membrane expression of ChIEF-tdTomato propagates
faster than 4.5 mm per day. Membrane proteins such as ChIEF are
delivered to the plasma membrane inserted into the walls of vesi-
cles after processing in the Golgi apparatus. The mechanisms of
targeted traffic of ChIEF or analogous optogenetic proteins along
the axons remain unclear and it is assumed that they reach the
distal axonal regions by lateral diffusion. However, this issue re-
quires future clarification.
Pulses of light applied to the whole cervical vagus nerve in
sheep triggered bursts of vagal efferent action potentials that
propagated at speeds of ~6 m s1. Robust activations of vagal
efferent fibers were observed with 1e2 ms long pulses of light and
required LED light power of >5mWmm2. These data indicate that
in sheep, the projections of the transduced DVMN vagal pregan-
glionic neurons have myelinated B fibre axons. Thus, it appears
(perhaps not surprisingly) that the DVMN neuronal axons of large
animals can conduct much faster than those of smaller mammals
(e.g. rats), in which the majority of vagal preganglionic neurons
located in the DVMN have C fibre axons, as reported previously [39]
and confirmed by the results of this study.
The method of targeted optogenetic stimulation of vagal fibers
described here may be useful for functional anatomical mapping of
the fascicular organization of the cervical vagus and other mixed
nerves. Surprisingly, the functional fascicular organization of the
vagus nerve in animals and humans remains completely unknown,
despite the widespread experimental and clinical applications of
the whole-nerve electrical VNS in conditions including refractory
epilepsy, heart failure, depression, and inflammation. A detailed
understanding of the fascicular organization of the vagus nerve in
large species is important for further development of the VNS
technology to allow targeted stimulation of a select group or subset
of vagal fibers. Such an understanding may extend our ability to
discriminate between fiber subsets beyond afferent and efferent to
include function- and organ-specific projections for targeted
stimulation at the cervical level.
In summary, this study demonstrates that in species with a large
diameter, multi-fascicled vagus nerve, it is possible to selectively
stimulate a specific group of nerve fibers using light. Recent95advances in human gene therapy map the way toward eventual
clinical applications of the optogenetic technology. Next genera-
tions of viral vectors may allow targeted transduction of desired
populations of vagal fibers projecting to or from individual organs
using vector delivery directly into the vagal trunk, for example
under ultrasound guidance. OptoVNS can then be applied at the
cervical level in order to stimulate or block the activity of specific
fibers with unparalleled precision and specificity.
Funding
This work was supported by the British Heart Foundation (Refs:
RG/14/4/30736 and RG/19/5/34463) and Medical Research Council
(Ref: MR/R01213X/1). A.V.G. is a Wellcome Trust Senior Research
Fellow (Ref: 095064). D.M., S.C.M. and Q.B. are supported by the
Hugo Charitable Trust. L.C.B, S.T.Y and C.N.M are supported by
NHMRC (Ref: 1128108). S.K. is supported by 5e100 programme.
S.T.Y. is an Australian Research Council Future Fellow (Ref:
FT170100363).
L.C.B., S.T.Y., A.K., D.G.S.F., S.G.H., S.J.M., W.S.K., S.M., P.L., G.L.A.,
R.M.M., C.N.M. and A.V.G. performed research; D.M., Q.B., S-J.G. and
S.C.M. designed the LED for light stimulation; A.A.C, A.G.T., S.K. and
A.M.A designed the viral vectors; L.C.B., S.T.Y., A.K., W.S.K. and A.V.G
analyzed the experimental data; L.C.B., S.T.Y., C.N.M. and A.V.G.
wrote the paper. All authors revised the article critically for
important intellectual content.
Declaration of competing interest
All authors declare no conflict of interest.
Appendix A. Supplementary data
Supplementary data to this article can be found online at
https://doi.org/10.1016/j.brs.2020.11.010.
References
[1] Famm K, Litt B, Tracey KJ, Boyden ES, Slaoui M. Drug discovery: a jump-start
for electroceuticals. Nature 2013;496:159e61.
[2] Bonaz B, Picq C, Sinniger V, Mayol JF, Clarencon D. Vagus nerve stimulation:
from epilepsy to the cholinergic anti-inflammatory pathway. Neuro Gastro-
enterol Motil 2013;25:208e21.
[3] Howland RH. Vagus nerve stimulation. Curr Behav Neurosci Rep 2014;1:
64e73.
[4] Yuan H, Silberstein SD. Vagus nerve and vagus nerve stimulation, a compre-
hensive review: Part I. Headache 2016;56:71e8.
[5] Yuan H, Silberstein SD. Vagus nerve and vagus nerve stimulation, a compre-
hensive review: Part II. Headache 2016;56:259e66.
[6] Byku M, Mann DL. Neuromodulation of the failing heart: lost in translation?
JACC Basic Transl Sci 2016;1:95e106.
[7] Hoffman HH, Schnitzlein HN. The numbers of nerve fibers in the vagus nerve
of man. Anat Rec 1961;139:429e35.
[8] Verlinden TJ, Rijkers K, Hoogland G, Herrler A. Morphology of the human
cervical vagus nerve: implications for vagus nerve stimulation treatment. Acta
Neurol Scand 2016;133:173e82.
[9] Hammer N, Loffler S, Cakmak YO, Ondruschka B, Planitzer U, Schultz M, et al.
Cervical vagus nerve morphometry and vascularity in the context of nerve
stimulation - a cadaveric study. Sci Rep 2018;8:7997.
[10] Ardell JL, Nier H, Hammer M, Southerland EM, Ardell CL, Beaumont E, et al.
Defining the neural fulcrum for chronic vagus nerve stimulation: implications
for integrated cardiac control. J Physiol 2017;595:6887e903.
[11] De Ferrari GM, Crijns HJ, Borggrefe M, Milasinovic G, Smid J, Zabel M, et al.
Chronic vagus nerve stimulation: a new and promising therapeutic approach
for chronic heart failure. Eur Heart J 2011;32:847e55.
[12] Zannad F, De Ferrari GM, Tuinenburg AE, Wright D, Brugada J, Butter C, et al.
Chronic vagal stimulation for the treatment of low ejection fraction heart
failure: results of the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF)
randomized controlled trial. Eur Heart J 2015;36:425e33.
[13] Deisseroth K, Hegemann P. The form and function of channelrhodopsin. Sci-
ence 2017;357.
[14] Xu X, Mee T, Jia X. New era of optogenetics: from the central to peripheral
nervous system. Crit Rev Biochem Mol Biol 2020;55:1e16.
L.C. Booth, S.T. Yao, A. Korsak et al. Brain Stimulation 14 (2021) 88e96[15] Towne C, Montgomery KL, Iyer SM, Deisseroth K, Delp SL. Optogenetic control
of targeted peripheral axons in freely moving animals. PloS One 2013;8:
e72691.
[16] Maimon BE, Zorzos AN, Bendell R, Harding A, Fahmi M, Srinivasan S, et al.
Transdermal optogenetic peripheral nerve stimulation. J Neural Eng 2017;14:
034002.
[17] Murthy SE, Loud MC, Daou I, Marshall KL, Schwaller F, Kuhnemund J, et al. The
mechanosensitive ion channel Piezo2 mediates sensitivity to mechanical pain
in mice. Sci Transl Med 2018;10.
[18] Hibberd TJ, Feng J, Luo J, Yang P, Samineni VK, Gereau RW, et al. Optogenetic
induction of colonic motility in mice. Gastroenterology 2018;155:514e28.
[19] Bai L, Mesgarzadeh S, Ramesh KS, Huey EL, Liu Y, Gray LA, et al. Genetic
identification of vagal sensory neurons that control feeding. Cell 2019;179:
1129e43.
[20] Anderson HE, Weir RFF. On the development of optical peripheral nerve in-
terfaces. Neural Regen Res 2019;14:425e36.
[21] Rajendran PS, Challis RC, Fowlkes CC, Hanna P, Tompkins JD, Jordan MC, et al.
Identification of peripheral neural circuits that regulate heart rate using
optogenetic and viral vector strategies. Nat Commun 2019;10:1944.
[22] Spencer NJ, Hibberd T, Feng J, Hu H. Optogenetic control of the enteric ner-
vous system and gastrointestinal transit. Expet Rev Gastroenterol Hepatol
2019;13:281e4.
[23] Pincus AB, Adhikary S, Lebold KM, Fryer AD, Jacoby DB. Optogenetic control of
airway cholinergic neurons in vivo. Am J Respir Cell Mol Biol 2020;62:423e9.
[24] Lin JY, Lin MZ, Steinbach P, Tsien RY. Characterization of engineered chan-
nelrhodopsin variants with improved properties and kinetics. Biophys J
2009;96:1803e14.
[25] Lonergan T, Teschemacher AG, Hwang D-Y, Kim K-S, Kasparov S. Targeting
brainstem centres of cardiovascular control using adenoviral vectors: impact
of promoters on transgene expression. Physiol Genom 2005;20:165e72.
[26] Mastitskaya S, Marina N, Gourine A, Gilbey MP, Spyer KM, Teschemacher AG,
et al. Cardioprotection evoked by remote ischaemic preconditioning is criti-
cally dependent on the activity of vagal pre-ganglionic neurones. Cardiovasc
Res 2012;95:487e94.
[27] Machhada A, Ang R, Ackland GL, Ninkina N, Buchman VL, Lythgoe MF, et al.
Control of ventricular excitability by neurons of the dorsal motor nucleus of
the vagus nerve. Heart Rhythm 2015;12:2285e93.96[28] Machhada A, Marina N, Korsak A, Stuckey DJ, Lythgoe MF, Gourine AV. Origins
of the vagal drive controlling left ventricular contractility. J Physiol 2016;594:
4017e30.
[29] Machhada A, Trapp S, Marina N, Stephens RCM, Whittle J, Lythgoe MF, et al.
Vagal determinants of exercise capacity. Nat Commun 2017;8:15097.
[30] Chang LJ, Urlacher V, Iwakuma T, Cui Y, Zucali J. Efficacy and safety analyses of
a recombinant human immunodeficiency virus type 1 derived vector system.
Gene Ther 1999;6:715e28.
[31] Coleman JE, Huentelman MJ, Kasparov S, Metcalfe BL, Paton JF, Katovich MJ,
et al. Efficient large-scale production and concentration of HIV-1-based len-
tiviral vectors for use in vivo. Physiol Genom 2003;12:221e8.
[32] Chen D, Bassi JK, Walther T, Thomas WG, Allen AM. Expression of angiotensin
type 1A receptors in C1 neurons restores the sympathoexcitation to angio-
tensin in the rostral ventrolateral medulla of angiotensin type 1A knockout
mice. Hypertension 2010;56:143e50.
[33] Benzekhroufa K, Liu BH, Teschemacher AG, Kasparov S. Targeting central
serotonergic neurons with lentiviral vectors based on a transcriptional
amplification strategy. Gene Ther 2009;16:681e8.
[34] Sastry L, Johnson T, Hobson MJ, Smucker B, Cornetta K. Titering lentiviral
vectors: comparison of DNA, RNA and marker expression methods. Gene Ther
2002;9:1155e62.
[35] Gourine AV, Dale N, Korsak A, Llaudet E, Tian F, Huckstepp R, et al. Release of
ATP and glutamate in the nucleus tractus solitarii mediate pulmonary stretch
receptor (Breuer-Hering) reflex pathway. J Physiol 2008;586:3963e78.
[36] Mastitskaya S, Turovsky E, Marina N, Theparambil SM, Hadjihambi A,
Kasparov S, et al. Astrocytes modulate baroreflex sensitivity at the level of the
nucleus of the solitary tract. J Neurosci 2020;40:3052e62.
[37] McAllen RM, Shafton AD, Bratton BO, Trevaks D, Furness JB. Calibration of
thresholds for functional engagement of vagal A, B and C fiber groups in vivo.
Bioelectron Med (Lond) 2018;1:21e7.
[38] Machhada A, Hosford PS, Dyson A, Ackland GL, Mastitskaya S, Gourine AV.
Optogenetic stimulation of vagal efferent activity preserves left ventricular
function in experimental heart failure. JACC Basic Transl Sci 2020;5:799e810.
[39] Jones JF, Wang Y, Jordan D. Activity of C fibre cardiac vagal efferents in
anaesthetized cats and rats. J Physiol 1998;507:869e80.
